2,827
Views
6
CrossRef citations to date
0
Altmetric
Articles

Examining the Vitamin D Status of Children With Solid Tumors

ORCID Icon, , &
Pages 128-134 | Received 19 Jan 2019, Accepted 03 May 2019, Published online: 06 Jun 2019

References

  • Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19(7):468–483. doi: 10.1016/j.annepidem.2009.03.021.
  • Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451–459. doi: 10.1093/jnci/djj101.
  • Wei MY, Giovannucci EL. Vitamin D and multiple health outcomes in the harvard cohorts. Mol Nutr Food Res. 2010;54(8):1114–1126.
  • Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, Shimojima A, Tamez S, Tsutsumi Y, Yanaga K, Urashima M. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer. 2010;10(1):347.
  • Li M, Chen P, Li J, Chu R, Xie D, Wang H. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(7):2327–2336. doi: 10.1210/jc.2013-4320.
  • Reichrath J, Reichrath S. Sunlight, vitamin D and malignant melanoma. Sunlight, vitamin D and skin cancer. Berlin: Springer; 2014. p. 390–405.
  • Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the us population, 1988–2004. Arch Intern Med. 2009;169(6):626–632. doi: 10.1001/archinternmed.2008.604.
  • Vásárhelyi B, Sátori A, Olajos F, Szabó A, Beko G. [Low vitamin D levels among patients at Semmelweis University: retrospective analysis during a one-year period]. Orv Hetil. 2011;152(32):1272–1277. doi: 10.1556/OH.2011.29187.
  • Barna M, György B. A D-vitamin újonnan felismert funkciói; 2012.
  • Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–188. doi: 10.1016/S0140-6736(10)60588-0.
  • Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842–856. doi: 10.1093/ajcn/69.5.842.
  • Szabo A. [skeletal and extra-skeletal consequences of vitamin D deficiency]. Orvosi Hetilap. 2011;152(33):1312–1319.
  • Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–78. doi: 10.1016/j.annepidem.2007.12.001.
  • Pearce S, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ. 2010;340:b5664. doi: 10.1136/bmj.b5664.
  • Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, et al. A global representation of vitamin D status in healthy populations. Arch Osteoporos. 2012;7:155–172. doi: 10.1007/s11657-012-0093-0.
  • Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32(3):210–216. doi: 10.1016/j.amepre.2006.11.004.
  • Kmieć P, Żmijewski M, Waszak P, Sworczak K, Lizakowska-Kmieć M. Vitamin D deficiency during winter months among an adult, predominantly urban, population in Northern Poland. Endokrynol Pol. 2014;65(2):105–113. doi: 10.5603/EP.2014.0015.
  • Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112(8):659
  • Eloi M, Horvath D, Szejnfeld V, Ortega J, Rocha D, Szejnfeld J, Castro C. Vitamin D deficiency and seasonal variation over the years in São Paulo, Brazil. Osteoporos Int. 2016;27(12):3449–3456. doi: 10.1007/s00198-016-3670-z.
  • Szolgálat OM. Elmúlt évek időjárása. In. Elmúlt Évek Időjárása; 2016.
  • Giovannucci E. Vitamin D status and cancer incidence and mortality. Sunlight, vitamin D and skin cancer. Berlin: Springer; 2008. p. 31–42.
  • Szabo A, Merke J, Beier E, Mall G, Ritz E. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int. 1989;35(4):1049–1056.
  • Vinh Quoc Luong K, Nguyen L. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol. 2010;73(3):192–201. doi: 10.1016/j.critrevonc.2009.04.008.
  • Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26(18):2984–2991. doi: 10.1200/JCO.2007.15.1027.
  • Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012;23(2):363–370. doi: 10.1007/s10552-011-9885-6.
  • Ren C, Qiu M-Z, Wang D-S, Luo H-y, Zhang D-S, Wang Z-Q, Wang F-h, Li Y-h, Zhou Z-W, Xu R-h. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med. 2012;10:16. doi: 10.1186/1479-5876-10-16.
  • Albert DM, Nickells RW, Gamm DM, Zimbric ML, Schlamp CL, Lindstrom MJ, Audo I. Vitamin D analogs, a new treatment for retinoblastoma: the first Ellsworth lecture. Ophthalmic Genet. 2002;23(3):137–156.
  • Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood. 2003;101(7):2454–2459. doi: 10.1182/blood-2002-07-1984.
  • Wang K, Dong M, Sheng W, Liu Q, Yu D, Dong Q, Li Q, Wang J. Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer. Histopathology. 2015;67(3):386–397. doi: 10.1111/his.12663.
  • Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–261. doi: 10.2105/AJPH.2004.045260.
  • Bittenbring JT, Neumann F, Altmann B, Achenbach M, Reichrath J, Ziepert M, Geisel J, Regitz E, Held G, Pfreundschuh M. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. JCO. 2014;32(29):3242–3248. doi: 10.1200/JCO.2013.53.4537.
  • Kubeczko M, Nowara E, Spychałowicz W, Wdowiak K, Bednarek A, Karwasiecka D, Chudek J, Wojnar J. Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia. Postepy Hig Med Dosw (Online). 2016;70(0):534–541. doi: 10.5604/17322693.1202482.